CNST
$25.45
Constellation Pharmaceuticals
$.44
1.76%
CNST
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  ($0.74)
Revenue:  $0.00 Mil
Thursday
Jan 28
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CNST reports earnings?
Beat
Meet
Miss

Where is CNST's stock price going from here?
Up
Flat
Down
Stock chart of CNST
Analysts
Summary of analysts' recommendations for CNST
Score
Grade
Pivots
Resistance
$26.70
$26.15
$25.80

$25.25

Support
$24.90
$24.35
$24.00
Tweet
Growth
Description
Constellation Pharmaceuticals, Inc. operates as a bio-pharmaceutical company. It discovers and develops molecule therapeutics for the treatment of cancer, inflammatory and immunologic disorders. The company's lead product candidates consists of CPI-1205, which inhibits enhancer of zeste homolog 2 and CPI-0610, which inhibits bromodomain and extra terminal domain. Constellation Pharmaceuticals, Inc. is based in Cambridge, United States.